Skip to content
GLP-1 Scorecard
Menu

Head-to-head · WeighScore

Cora Health vs eMed

Cora Health
Graded #76

Higher grade

vs+15.100000000000001
eMed
Graded #398

Lower grade

The verdict

Cora Health takes it — 72.5/100 to 57.4/100.

Cora Health grades higher on WeighScore, our editorial score across cost value, dose & formulation, clinical oversight, labs & monitoring, fulfillment and contract terms. Cora Health is a direct-to-consumer telehealth platform offering compounded semaglutide ($99–$175/mo) and tirzepatide ($135–$225/mo) with flat per-tier pricing — no surcharge as your dose escalates.

We may earn a commission if you start care through some of these links, at no extra cost to you. It never moves the WeighScore, which is the weighted average of the six factors shown for every provider, and what we write about a provider is the same either way. See our disclosure.

Factor by factor

The same six graded dimensions, side by side. See the methodology.

Cost valueCora Health +29
74
45
Dose & formulationCora Health +32
72
40
Clinical oversighteMed +1
82
83
Labs & monitoringeMed +11
54
65
FulfillmentCora Health +27
89
62
Contract termsEven
55
55
Cora Health · left bareMed · right bar

The numbers

MetricCora HealtheMed
WeighScore72.5/10057.4/100
GradeCC
Scorecard rank#76#398
Semaglutide$175/moNot disclosed
Tirzepatide$225/moNot disclosed
CoverageAll 50 statesCoverage not published
Brand-name accessCompounded onlyCompounded only
Oral / sublingualInjection onlyInjection only
Cora Health

Graded #76 · C

Strengths

  • Two named 503A compounding pharmacy partners disclosed on first-party pages (Hallandale Pharmacy + VialsRx)
  • Hallandale Pharmacy is PCAB-accredited and operating since 2003 (independently verified)
  • LegitScript Certified (seal ID 49690100 in footer)
  • Flat per-tier pricing — no dose-escalation surcharge
  • Annual commitment delivers $99/mo semaglutide and $135/mo tirzepatide

Where it loses points

  • Compounded medications are not FDA-approved and not therapeutically equivalent to Wegovy/Zepbound
  • Leanio Health LLC has zero independent operating-history footprint (no BBB, no press, likely <12 months old)
  • Lowest advertised prices require 12-month commitment with no partial refunds
  • No brand-name Wegovy/Zepbound or oral GLP-1 (orforglipron/Rybelsus) options
  • Founder names and funding undisclosed on site
eMed

Graded #398 · C

Strengths

  • Prescribes FDA-approved branded GLP-1s (semaglutide and tirzepatide)
  • At-home blood collection makes lab work convenient
  • Clinician review and ongoing side-effect plus adherence support
  • Works with CVS Caremark so eligible employees can buy through benefits
  • Established digital health company with national scale

Where it loses points

  • Distributed mainly via employers, with limited direct cash-pay access
  • No public transparent monthly price for individuals
  • Eligibility and subsidy depend on what the employer chooses to cover
  • Best suited to workforces, not casual self-pay shoppers

Also worth a look

Neither is our top-graded pick — CoreAge Rx leads the scorecard

Across all 499 providers, CoreAge Rx grades highest at 91.8/100 (A−). Top of the scorecard: flat transparent pricing, both molecules, nationwide — no teaser-rate games.

Pricing/verification reflect each provider's public disclosures at last grading; the WeighScore is our editorial judgment per the methodology. Prices change — confirm on each provider's site. Not medical advice; see our disclosure.

← Back to the scorecard